يۇقىرىدىكى يازمامدا رىشات ئابباسنىڭ 2013-يىلدىكى بىر ماقالىسى "دۇنيا بىو-مەدىتسىنا ئالدىنقى سەپى” ژۇرنىلىنىڭ ئالدى مۇقاۋا بېتىدە تونۇشتۇرۇلۇشقا تەكلىپ قىلىنىپتۇ دەپ يازغان ئىدىم. تۆۋەندىكى خەت بۇ ژۇرنالنىڭ باش تەھرىرى دوكتور رىشات ئابباسقا يازغان تەكلىپىنىڭ ئىنگلىزچە نۇسخىسى.
Dear Dr. Abbas:
Your recent paper about cancer: “Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects” (published in “cancer chemotherapy and pharmacology.2013 Jan;71(1):123-132.”) has been selected to be featured in our next issue of World Biomedical Frontiers, because of its innovation and potential for significant impact.
Research results with significant potential to improve health – or to treat or prevent disease – often deserve an immediate leap onto the “front page”. However, scientific breakthroughs don't always make the front page – and some don't make any page! We are the platform for you to stand out from among ~100,000 papers published each month, in order toattract more attention from the public and potential investors.
World Biomedical Frontiers [ISSN: 2328-0166] focuses on cutting-edge biomedical research from around the globe. Our website receives more than 11,000 visits per month from an international audience of academic and industrial researchers and developers, providing greater opportunity for your results to be recognized and appreciated.
Sincerely,
Michael S. Yang, MD, PhD
Editor
World Biomedical Frontiers, LLC
New York, USA
Phone: 1-(917) 426-1571
E-mails:
editors@biomedfrontiers.org
Website:
http://biomedfrontiers.org/